Cargando…

SLC6A14 and SLC38A5 Drive the Glutaminolysis and Serine–Glycine–One-Carbon Pathways in Cancer

The glutaminolysis and serine–glycine–one-carbon pathways represent metabolic reactions that are reprogramed and upregulated in cancer; these pathways are involved in supporting the growth and proliferation of cancer cells. Glutaminolysis participates in the production of lactate, an oncometabolite,...

Descripción completa

Detalles Bibliográficos
Autores principales: Sniegowski, Tyler, Korac, Ksenija, Bhutia, Yangzom D., Ganapathy, Vadivel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000594/
https://www.ncbi.nlm.nih.gov/pubmed/33806675
http://dx.doi.org/10.3390/ph14030216
_version_ 1783671033380732928
author Sniegowski, Tyler
Korac, Ksenija
Bhutia, Yangzom D.
Ganapathy, Vadivel
author_facet Sniegowski, Tyler
Korac, Ksenija
Bhutia, Yangzom D.
Ganapathy, Vadivel
author_sort Sniegowski, Tyler
collection PubMed
description The glutaminolysis and serine–glycine–one-carbon pathways represent metabolic reactions that are reprogramed and upregulated in cancer; these pathways are involved in supporting the growth and proliferation of cancer cells. Glutaminolysis participates in the production of lactate, an oncometabolite, and also in anabolic reactions leading to the synthesis of fatty acids and cholesterol. The serine–glycine–one-carbon pathway is involved in the synthesis of purines and pyrimidines and the control of the epigenetic signature (DNA methylation, histone methylation) in cancer cells. Methionine is obligatory for most of the methyl-transfer reactions in the form of S-adenosylmethionine; here, too, the serine–glycine–one-carbon pathway is necessary for the resynthesis of methionine following the methyl-transfer reaction. Glutamine, serine, glycine, and methionine are obligatory to fuel these metabolic pathways. The first three amino acids can be synthesized endogenously to some extent, but the need for these amino acids in cancer cells is so high that they also have to be acquired from extracellular sources. Methionine is an essential amino acid, thus making it necessary for cancer cells to acquire this amino acid solely from the extracellular milieu. Cancer cells upregulate specific amino acid transporters to meet this increased demand for these four amino acids. SLC6A14 and SLC38A5 are the two transporters that are upregulated in a variety of cancers to mediate the influx of glutamine, serine, glycine, and methionine into cancer cells. SLC6A14 is a Na(+)/Cl(−) -coupled transporter for multiple amino acids, including these four amino acids. In contrast, SLC38A5 is a Na(+)-coupled transporter with rather restricted specificity towards glutamine, serine, glycine, and methionine. Both transporters exhibit unique functional features that are ideal for the rapid proliferation of cancer cells. As such, these two amino acid transporters play a critical role in promoting the survival and growth of cancer cells and hence represent novel, hitherto largely unexplored, targets for cancer therapy.
format Online
Article
Text
id pubmed-8000594
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80005942021-03-28 SLC6A14 and SLC38A5 Drive the Glutaminolysis and Serine–Glycine–One-Carbon Pathways in Cancer Sniegowski, Tyler Korac, Ksenija Bhutia, Yangzom D. Ganapathy, Vadivel Pharmaceuticals (Basel) Review The glutaminolysis and serine–glycine–one-carbon pathways represent metabolic reactions that are reprogramed and upregulated in cancer; these pathways are involved in supporting the growth and proliferation of cancer cells. Glutaminolysis participates in the production of lactate, an oncometabolite, and also in anabolic reactions leading to the synthesis of fatty acids and cholesterol. The serine–glycine–one-carbon pathway is involved in the synthesis of purines and pyrimidines and the control of the epigenetic signature (DNA methylation, histone methylation) in cancer cells. Methionine is obligatory for most of the methyl-transfer reactions in the form of S-adenosylmethionine; here, too, the serine–glycine–one-carbon pathway is necessary for the resynthesis of methionine following the methyl-transfer reaction. Glutamine, serine, glycine, and methionine are obligatory to fuel these metabolic pathways. The first three amino acids can be synthesized endogenously to some extent, but the need for these amino acids in cancer cells is so high that they also have to be acquired from extracellular sources. Methionine is an essential amino acid, thus making it necessary for cancer cells to acquire this amino acid solely from the extracellular milieu. Cancer cells upregulate specific amino acid transporters to meet this increased demand for these four amino acids. SLC6A14 and SLC38A5 are the two transporters that are upregulated in a variety of cancers to mediate the influx of glutamine, serine, glycine, and methionine into cancer cells. SLC6A14 is a Na(+)/Cl(−) -coupled transporter for multiple amino acids, including these four amino acids. In contrast, SLC38A5 is a Na(+)-coupled transporter with rather restricted specificity towards glutamine, serine, glycine, and methionine. Both transporters exhibit unique functional features that are ideal for the rapid proliferation of cancer cells. As such, these two amino acid transporters play a critical role in promoting the survival and growth of cancer cells and hence represent novel, hitherto largely unexplored, targets for cancer therapy. MDPI 2021-03-04 /pmc/articles/PMC8000594/ /pubmed/33806675 http://dx.doi.org/10.3390/ph14030216 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Review
Sniegowski, Tyler
Korac, Ksenija
Bhutia, Yangzom D.
Ganapathy, Vadivel
SLC6A14 and SLC38A5 Drive the Glutaminolysis and Serine–Glycine–One-Carbon Pathways in Cancer
title SLC6A14 and SLC38A5 Drive the Glutaminolysis and Serine–Glycine–One-Carbon Pathways in Cancer
title_full SLC6A14 and SLC38A5 Drive the Glutaminolysis and Serine–Glycine–One-Carbon Pathways in Cancer
title_fullStr SLC6A14 and SLC38A5 Drive the Glutaminolysis and Serine–Glycine–One-Carbon Pathways in Cancer
title_full_unstemmed SLC6A14 and SLC38A5 Drive the Glutaminolysis and Serine–Glycine–One-Carbon Pathways in Cancer
title_short SLC6A14 and SLC38A5 Drive the Glutaminolysis and Serine–Glycine–One-Carbon Pathways in Cancer
title_sort slc6a14 and slc38a5 drive the glutaminolysis and serine–glycine–one-carbon pathways in cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000594/
https://www.ncbi.nlm.nih.gov/pubmed/33806675
http://dx.doi.org/10.3390/ph14030216
work_keys_str_mv AT sniegowskityler slc6a14andslc38a5drivetheglutaminolysisandserineglycineonecarbonpathwaysincancer
AT koracksenija slc6a14andslc38a5drivetheglutaminolysisandserineglycineonecarbonpathwaysincancer
AT bhutiayangzomd slc6a14andslc38a5drivetheglutaminolysisandserineglycineonecarbonpathwaysincancer
AT ganapathyvadivel slc6a14andslc38a5drivetheglutaminolysisandserineglycineonecarbonpathwaysincancer